CVS Health Corporation CVS shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also raised FY21 EPS guidance above estimates.
The company reported first-quarter earnings per share of $2.04, which beat the $1.71 estimate, and sales results of $69.10 billion, which beat the $68.39 billion estimate.
The company also raised its full-year 2021 earnings per share guidance from $7.39-$7.55 to $7.56-$7.68 versus the $7.53 estimate.
CVS Health provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions.
CVS Health shares were trading 3% higher at $80.02 on Tuesday. The stock set a new 52-week high of $80.75 and has a 52-week low of $55.36.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.